Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya케냐 코로나19 예방접종의 역학적 영향 및 비용 효율성 분석Article Published on 2022-08-012022-09-11 Journal: BMJ Global Health [Category] SARS, 변종, [키워드] analyses Analysis assumed conducted Cost-effectiveness analysis Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death dose epidemiological Epidemiology Frame health economics Immune escape Increasing introduced Kenya natural immunity Perspective Rapid reduced SARS-COV-2 infection slow target threshold Time frame Transmission model vaccination Vaccine Vaccines variant [DOI] 10.1136/bmjgh-2022-009430 PMC 바로가기 [Article Type] Article
COVID-19 Testing Strategies for K-12 Schools in California: A Cost-Effectiveness Analysis캘리포니아의 K-12 학교를 위한 COVID-19 테스트 전략: 비용 효율성 분석Article Published on 2022-07-302022-09-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 변종, [키워드] Analysis Antigen Asymptomatic benefit community transmission conducted Cost effectiveness Cost-effectiveness analysis COVID-19 COVID-19 pandemic declines Follow-up Frequency Guidance Health help individuals Infection K-12 moderate omicron PCR PCR test PCR tests positive Prevalence Public Quality-Adjusted Life Years reduce resource SARS-CoV-2 antigen School Schools Screening screening strategy Secondary infection secondary infections Sensitivity analyses sensitivity analysis Strategy Testing Transmission twice weekly variant Weekly widespread [DOI] 10.3390/ijerph19159371 PMC 바로가기 [Article Type] Article
Cost-effectiveness analysis of an active search to retrieve HCV patients lost to follow-up (RELINK-C strategy) and the impact of COVID-19추적 조사에 실패한 HCV 환자를 검색하기 위한 적극적인 검색(RELINK-C 전략) 및 COVID-19의 영향에 대한 비용 효율성 분석Article Published on 2022-07-012022-09-11 Journal: Journal of viral hepatitis [Category] 치료제, [키워드] Abstract Cost-effectiveness analysis COVID-19 COVID-19 pandemic Follow-up HCV Hepatitis hepatitis C hepatitis C elimination linkage linkage to care lost to follow-up patients. Patient patients [DOI] 10.1111/jvh.13686 PMC 바로가기 [Article Type] Article
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mLArticle Published on 2022-04-012023-06-12 Journal: Hepatology international [Category] B형 간염, [키워드] antiviral therapy compensated cirrhosis Cost-effectiveness analysis Hepatitis B virus Low-level viremia [DOI] 10.1007/s12072-022-10310-1
Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea국내 SARS-CoV-2에 대한 경구용 항바이러스제의 모델 기반 비용 효율성 분석Article Published on 2022-01-012022-09-11 Journal: Epidemiology and Health [Category] SARS, 치료제, [키워드] Admission Adult patients Adults Analysis Antiviral antiviral agent Antiviral agents calculated Care coronavirus disease Coronavirus disease 2019 Cost-effectiveness analysis country COVID-19 COVID-19 patient Efficacy Elderly patient elderly patients Emergency use group health system Hospital admission Hospitalization ICU less medical system Mild-to-moderate molnupiravir Nirmatrelvir Patient patients predicted reduce reducing Ritonavir SARS-CoV-2 Severe case severe COVID-19 Severe patient standard care symptomatic Treatment underlying disease underlying diseases [DOI] 10.4178/epih.e2022034 PMC 바로가기 [Article Type] Article
COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for IranArticle Published on 2021-12-292022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Ad26.COV2.S Analysis BNT162b2 calculate CoronaVac Cost-effectiveness analysis COVID-19 COVID-19 vaccine COVID-19 vaccines Critical death Effectiveness highest include Iran lowest pandemic SARS-CoV-2 SARS-CoV-2 vaccines scenario vaccination Vaccine with COVID-19 [DOI] 10.3390/vaccines10010037 PMC 바로가기 [Article Type] Article
A Systematic Review of Economic Evaluations of Active Tuberculosis Treatmentsarticle Published on 2021-12-132024-09-02 Journal: Frontiers in Pharmacology [Category] 대상포진, [키워드] Cost-effectiveness analysis Cost-utility analysis Economic evaluation systematic review Tuberculosis [DOI] 10.3389/fphar.2021.736986 PMC 바로가기 [Article Type] article
Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios다양한 시나리오에서 중국의 중증 COVID-19 환자 치료를 위한 렘데시비르의 경제적 평가Article Published on 2021-11-012022-09-11 Journal: British Journal of Clinical Pharmacology [Category] 치료제, [키워드] analysed Analysis Asymptomatic calibrated calibration China cost-effectiveness Cost-effectiveness analysis COVID-19 Decision tree disease Epidemic epidemic curve evaluate Evidence Health Healthcare system Hospitalized intensities life outcome parameter variation parameters Patient Perspective presymptomatic Quality of life regimen Remdesivir replaced REPLACED BY representing robust Sensitivity analyses Severe case severe cases severe COVID-19 patient severe COVID-19 patients Standard of care threshold Transmission model Treatment Wuhan [DOI] 10.1111/bcp.14860 PMC 바로가기 [Article Type] Article
Prioritization of the Target Population for Coronavirus Disease 2019 (COVID-19) Vaccination Program in ThailandArticle Published on 2021-10-142022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS, [키워드] Analysis analyzed assumed comparable compartmental model Cost-benefit analysis Cost-effectiveness analysis COVID-19 COVID-19 vaccination COVID-19 vaccine cumulative death demonstrated Economic evaluation Effectiveness feasibility independent Infection lowest migrant outcome Population predict Prevent produced Program Public Reproduction number second wave target vaccination Vaccine Volume [DOI] 10.3390/ijerph182010803 PMC 바로가기 [Article Type] Article
Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling studyArticle Published on 2021-10-082023-05-31 Journal: Vaccine [Category] A형 간염, [키워드] Catch-up vaccination Cost-effectiveness analysis Dynamic transmission model Hepatitis A vaccine hepatitis A virus herd protection/immunity Simulation [DOI] 10.1016/j.vaccine.2021.08.087